Cost Structure (Mylan / EpiPen)
Last Updated by Anonymous | Update This Page Delete This Page
A weak cost structure means Mylan / EpiPen’s costs are high in comparison to their competitors… … "Cost Structure (Mylan / EpiPen)" will have a long-term negative impact on this entity, which subtracts from the entity's value. This statements will have a short-term negative impact on this entity, which subtracts from its value.
SWOT Analysis Survey
SWOT Weakness: Cost Structure (Mylan / EpiPen)
A weak cost structure means Mylan / EpiPen’s costs are high in comparison to their competitors…
[[div class="delete-prompt" style="display : none;"]]
If you believe that this point is inaccurate, please flag this page to notify administrators and moderators.